Login
$RIGL
$50.74 +$0.19 (0.38%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Raul R. Rodriguez Also a director
President, Chief Executive Officer and Director
65 Not stated Not stated $4,658,805
Dean L. Schorno
Executive Vice President and Chief Financial Officer
63 Since 2018
8 years
Not stated $1,822,409
Raymond J. Furey
EVP, GC, CCO & Corp Sec
Title from the Form 4 dated Sep 1, 2026
58 Not stated Not stated $1,769,502
David A. Santos
Executive Vice President and Chief Commercial Officer
63 Since 2020
6 years
Not stated $1,831,604
Lisa Rojkjaer
Executive Vice President and Chief Medical Officer
60 Since 2024
2 years
Not stated $1,830,175
Alison L. Hannah Also a director
EVP, Chief Medical Officer
Title from the Form 4 dated Jul 8, 2026
65 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
8.5 years
from year joined
CEO also chairs the board
No
Gregg A. Lapointe
Director Age On board Independent Committees Other public boards 2025 pay Source
Gregg A. Lapointe
67 2017
9 years
Independent None stated Soligenix, Inc., Astria Therapeutics, Inc. $217,767
Raul R. Rodriguez
65 2014
12 years
Not independent
Finance Committee
None stated Paid as CEO
Alison L. Hannah
65 2021
5 years
Independent None stated None stated $165,767
Walter H. Moos
71 1997
29 years
Independent None stated Valitor, Inc., Circle Pharma, Inc., Organos, Inc. Not stated
Mark W. Frohlich
64 2025
1 year
Independent
Governance Committee Scientific and Clinical Trial Advisory Committee
None stated $288,620
Michael P. Miller
69 2026
0 years
Independent
Compensation Committee
Puma Biotechnology, Inc., BioXcel Not stated
Kamil Ali-Jackson
67 2021
5 years
Independent None stated PDS Biotechnology Corporation Not stated
Jane Wasman
69 2019
7 years
Independent None stated Sellas Life Sciences $172,767

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 3, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support